跳至主要内容
临床试验/JPRN-jRCT1051220090
JPRN-jRCT1051220090招募中Unknown

A study of treatment of lungs diseases with human-derived mesenchymal stem cell conditioned medium

Inami Norihito Norihito0 个研究点目标入组 20 人开始时间: 2022年9月14日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Patients who did not have a satisfactory therapeutic effect with standard treatment by a respiratory physician
  • 2. Patients who do not wish to be treated with the drugs used in standard treatment due to concerns about side effects, etc., and those who have been judged by the doctor that chronic pain treatment with conditioned medium is optimal.
  • Target patients who meet the following criteria.
  • 1. 18 years old and over
  • 2. Have normal consent ability
  • 3. Those who have been diagnosed with diffuse panbronchioles, interstitial lung disease, chronic obstructive pulmonary disease (COPD) or have symptoms of respiratory distress and have lung disease that the doctor has determined to be appropriate treatment. direction
  • 4. Patients who can obtain their free will consent in writing
  • 5. Patients whose doctor have recognized the need for treatment

排除标准

  • Patient who meet any of the following conditions are excluded
  • 1. Have a history of or suspected of dementia
  • 2. Users of narcotics or stimulants
  • 3. Pregnant, breastfeeding
  • 4. Judged unsuitable by the doctor

研究者

发起方
Inami Norihito Norihito

相似试验